| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | 12 | — | — | 1 | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 1.92 |
—
—
—
|
| 2025 | 1.72 |
—
—
—
—
|
| 2024 | 1.50 |
—
—
—
—
|
| 2023 | 0.54 |
—
—
—
—
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡‡ |
|
| 2019 | ‡‡‡‡ |
|
| 2018 | ‡‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 921.23 | 651.56 | 775.16 | 807.27 |
| Receivables | 266.97 | 256.28 | 306.96 | 304.10 |
| Inventory | — | — | — | — |
| Other | 111.36 | 192.41 | 174.17 | 168.98 |
| 1,299.56 | 1,100.24 | 1,256.28 | 1,280.34 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 271.65 | 212.48 | 200.68 | 215.74 |
| ST’ Debt | — | — | — | — |
| Other | 36.61 | 20.51 | 9.21 | 10.02 |
| 733.02 | 685.20 | 597.59 | 649.62 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1,123.47 | 1,408.42 | — | — |
—
|
| ’25 | 1,364.61 | 1,633.41 | 1,423.86 | 1,435.76 |
5,857.64
|
| ’24 | 1,474.75 | 1,702.05 | 1,596.52 | 1,621.71 |
6,395.04
|
| ’23 | 1,285.04 | 1,573.61 | 1,619.21 | 1,660.41 |
6,138.26
|
| ’22 | 1,291.61 | 1,417.52 | 1,584.33 | 1,998.75 |
6,292.20
|
| ’21 | 1,088.53 | 1,283.26 | 1,265.11 | 1,504.41 |
5,141.32
|
| ’20 | 904.93 | 1,037.56 | 1,143.03 | 1,415.71 |
4,501.22
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 101.31 | 189.47 | — | — |
—
|
| ’25 | (42.58) | 13.70 | (96.51) | 243.67 |
118.29
|
| ’24 | 81.93 | (117.95) | (92.00) | (99.56) |
(227.58)
|
| ’23 | 124.47 | 231.41 | 104.21 | (104.52) |
355.57
|
| ’22 | 12.19 | (219.01) | 37.02 | 575.08 |
405.27
|
| ’21 | (13.95) | (129.53) | (105.23) | 96.61 |
(152.09)
|
| ’20 | 43.91 | 193.53 | 135.64 | 157.28 |
530.36
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 97.10 | 184.00 | — | — |
—
|
| ’25 | (48.14) | 7.03 | (104.24) | 238.16 |
92.82
|
| ’24 | 75.75 | (124.80) | (99.96) | (106.96) |
(255.97)
|
| ’23 | 115.70 | 219.28 | 94.23 | (111.40) |
317.80
|
| ’22 | 5.94 | (225.37) | 30.41 | 567.80 |
378.78
|
| ’21 | (18.85) | (135.29) | (112.06) | 89.01 |
(177.20)
|
| ’20 | 38.68 | 188.68 | 131.48 | 152.29 |
511.13
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.82 | 1.37 | — | — |
—
|
| ’25 | 1.69 | 2.04 | 1.39 | 1.20 |
6.35
|
| ’24 | 2.53 | 3.16 | 2.67 | 4.72 |
21.44
|
| ’23 | 1.77 | 2.51 | 2.99 | 2.69 |
9.97
|
| ’22 | 2.90 | 3.39 | 3.55 | 3.55 |
13.37
|
| ’21 | 1.72 | 2.18 | 2.63 | 3.13 |
9.65
|
| ’20 | 0.92 | 1.19 | 1.42 | 1.99 |
5.50
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 31.26 | 46.15 | 73.89 | 59.27 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 61.65 | 89.41 | 106.99 | 84.74 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 995 | 910 | 1,898 | 1,860 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.32 | 6.75 | 3.37 | 3.15 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,292.20 | 6,138.26 | 6,395.04 | 5,857.64 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.74% | 24.96% | 25.25% | 19.99% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,289.32 | 949.43 | 1,002.87 | 584.60 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.49% | 15.47% | 15.68% | 9.98% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 992.19 | 738.75 | 786.19 | 453.01 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.75 | 25.33 | 25.96 | 25.29 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 85.74 | 83.81 | 88.24 | 82.71 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.52 | 10.09 | 21.70 | 6.40 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.52 | 4.86 | (3.14) | 1.67 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.36) | (0.52) | (0.39) | (0.36) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.16 | 4.34 | (3.53) | 1.31 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 53.82 | 62.97 | 70.94 | 73.37 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 73.39 | 73.24 | 72.48 | 70.82 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.45 | 8.46 | 5.81 | 10.31 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.54 | 1.02 | 0.87 | 0.80 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.87 | 1.36 | 1.08 | 0.90 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.59 | 1.04 | 0.99 | 0.98 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.84 | 20.11 | (24.65) | 62.12 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 405.27 | 355.57 | (227.58) | 118.29 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (26.49) | (37.77) | (28.40) | (25.47) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 378.78 | 317.80 | (255.97) | 92.82 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 481.47 | 566.54 | 415.04 | 658.69 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,150.65 | 1,008.22 | 1,335.88 | 1,829.05 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 289.09 | 86.99 | 684.32 | 1,053.90 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,949.61 | 4,611.90 | 5,141.57 | 5,195.64 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.76% | 12.19% | 11.63% | 6.13% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.97% | 12.00% | 10.28% | 5.40% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.37% | 17.26% | 16.12% | 8.76% | — | — | — |
ROE
|
Meritage Homes (MTH), a top U.S. builder of affordable single-family homes, rode the post-pandemic housing boom to peak revenues of $6.39 billion in 2024—a 110% surge from 2016—fueled by low rates and supply shortages that boosted margins to 28.7% and EPS to $21.70. Yet, Fed hikes since 2022 triggered a pivot: 2023 revenues dipped 2.5%, with analysts forecasting an 8.4% drop to $5.86 billion in 2025 before a rebound to $6.39 billion by 2027, alongside EPS sliding to $5.79 in 2026 amid margin compression to 10%.
A rock-solid balance sheet—equity up 262% to $5.14 billion, shares reduced 10% via buybacks—offers downside protection, with valuations screaming value at forward PE of 11-14x versus historical 7-9x averages. Insiders show modest director buys amid routine exec sells, while analyst targets imply 2% mean upside (up to 18% high) if rate cuts revive demand for entry-level homes. This cyclical setup rewards patient investors eyeing a snapback.
Read the full analysis for detailed trends, FCF swings, ROE peaks at 28.4%, and why MTH stands out in housing’s next cycle.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.